Marilena Vrana/LinkedIn
Oct 5, 2025, 11:50
Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“Europe’s plasma supply chain is at a critical juncture, and current policies are not equipped to fix it.
In my latest opinion piece The Brussels Times, I break down why plasma-derived medicines require a holistic policy approach – especially as the Critical Medicines Act takes shape.
- Europe’s dependence on US plasma
- Why PDMPs don’t fit policies designed to tackle supply chains of chemically synthesized pharmaceuticals
- The pitfalls of “one-size-fits-all” approach
- The importance of collaboration
If we, Europeans, aim to achieve strategic autonomy and security of medicines supply, our policies must be grounded in reality.
International Plasma Awareness Week, which starts on October 6th, offers the perfect moment to reset Europe’s approach.”
Read more here.
Stay updated with Hemostasis Today.
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
-
Dec 16, 2025, 11:30Kingsley Wheaton: Sweden is on the Brink of Becoming the World’s 1st Smoke-Free Country
-
Dec 16, 2025, 11:03Matías J Alet on CABOS Project with The Support of WSO
-
Dec 16, 2025, 00:32New on EHCucate: Read about the “History of Replacement Factor Therapies” and More